BiotechTube

MKC-1

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Ovarian Cancer

Conditions

Ovarian Cancer, Endometrial Cancer

Trial Timeline

Jan 1, 2008 → Jan 1, 2012

NCT ID
NCT00607607

About MKC-1

MKC-1 is a phase 2 stage product being developed by CASI Pharmaceuticals for Ovarian Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT00607607. Target conditions include Ovarian Cancer, Endometrial Cancer.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (5)

NCT IDPhaseStatus
NCT00656461Phase 1Completed
NCT00607607Phase 2Completed
NCT00568646Phase 2Completed
NCT00506402Phase 1Completed
NCT00306631Phase 2Completed

Competing Products

20 competing products in Ovarian Cancer

See all competitors
ProductCompanyStageHype Score
azenosertibZentalis PharmaceuticalsPhase 2
44
Azenosertib + NiraparibZentalis PharmaceuticalsPhase 1/2
33
pemetrexed + topotecanEli LillyPhase 1
33
arzoxifene hydrochlorideEli LillyPhase 2
52
LY4337713Eli LillyPhase 1
33
PrexasertibEli LillyPhase 2
52
Durvalumab + BA3011 + BA3021 + ENB003 + ToripalimabBioAtlaPhase 2
44
Gemcitabine + Oxaliplatin + BevacizumabEli LillyPhase 2
52
Raludotatug Deruxtecan + Carboplatin + Paclitaxel + Bevacizumab + Rescue Medication + PembrolizumabDaiichi SankyoPhase 1/2
41
Trastzumab Deruxtecan + Bevacizumab + Platinum Based ChemotherapyDaiichi SankyoPhase 2
52
Trastuzumab Deruxtecan + BevacizumabDaiichi SankyoPhase 3
77
Trastuzumab deruxtecanDaiichi SankyoPhase 2
52
Trastuzumab deruxtecanDaiichi SankyoPhase 2
52
CS-1008 + Paclitaxel + CarboplatinDaiichi SankyoPhase 2
52
OSI-906 + PaclitaxelAstellas PharmaPhase 1/2
41
Enzalutamide 40 MGAstellas PharmaPhase 2
52
ASP0739Astellas PharmaPhase 1/2
41
IMAB027Astellas PharmaPhase 1
33
OSI-211 (Liposomal Lurtotecan)Astellas PharmaPhase 2
52
Triptorelin for Injection + Recombinant Human Choriogonadotropin alfa Solution for Injection + Progesterone Soft CapsulesSun PharmaceuticalPhase 3
77

Other Products from CASI Pharmaceuticals

Melphalan Hydrochloride for InjectionApproved
77
Panzem NCD + TemozolomidePhase 2
44
Panzem (2-methoxyestradiol) NCD, Avastin (Bevacizumab)Phase 2
44
ENMD-2076Phase 2
44
Panzem Nanocrystal Colloidal Dispersion (NCD)Phase 2
44